Loading...

Media is loading
 

Date of Award

Spring 2020

Degree Name

Master of Medical Science (Physician Assistant)

Department

Physician Assistant; College of Health Sciences

First Advisor

Michael Huber, MMS, PA-C, DFAAPA

Abstract

Obstructive sleep apnea (OSA) is a common comorbidity found in patients with Type 2 diabetes (T2DM) and has been identified as an independent risk factor in developing T2DM. Continuous positive airway pressure (CPAP) is the first line treatment for OSA. This study reviewed six articles that assessed the impact of CPAP treatment on glycemic control in patients with T2DM and OSA compared to no treatment. The results showed that CPAP does not lead to improved glycemic control in the short term but may be associated with a slower rise in hemoglobin A1c (HbA1c) in the long term. CPAP treatment led to significant improvements in blood pressure and sleep scores, supporting the use of CPAP in patients with T2DM and OSA regardless of its effect on HbA1c.

Download

Additional Files

Poster Presentation PDF.pdf (11329 kB)
References.docx (17 kB)

Share

COinS
 

The impact of CPAP therapy on glycemic control in patients with obstructive sleep apnea and type 2 diabetes

Obstructive sleep apnea (OSA) is a common comorbidity found in patients with Type 2 diabetes (T2DM) and has been identified as an independent risk factor in developing T2DM. Continuous positive airway pressure (CPAP) is the first line treatment for OSA. This study reviewed six articles that assessed the impact of CPAP treatment on glycemic control in patients with T2DM and OSA compared to no treatment. The results showed that CPAP does not lead to improved glycemic control in the short term but may be associated with a slower rise in hemoglobin A1c (HbA1c) in the long term. CPAP treatment led to significant improvements in blood pressure and sleep scores, supporting the use of CPAP in patients with T2DM and OSA regardless of its effect on HbA1c.